Stock Track | Medtronic Plunges 5.06% in Pre-market as Fiscal 2026 Guidance Falls Short of Estimates

Stock Track
02/17

Medtronic PLC's stock fell sharply by 5.06% in pre-market trading, following the release of the company's third-quarter fiscal 2026 financial results and updated guidance.

While the medical device maker reported strong quarterly performance, with adjusted earnings per share of $1.36 beating the IBES estimate of $1.33 and revenue of $9,000 million surpassing the $8,905 million estimate, investors focused on the company's outlook. Medtronic provided fiscal 2026 adjusted EPS guidance in the range of $5.62 to $5.66, which came in below the FactSet consensus estimate of $5.72.

The market's negative reaction highlights investor concerns over the company's future earnings potential, overshadowing the positive third-quarter results that included the highest enterprise revenue growth in ten quarters.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10